StockData
PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Picard Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)

Close on Oct 19, 2026

Market cap
$28.67M
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Picard Medical's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Sander Gerber11,390,4429.99%13G (passive) amendmentJun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Patrick Nj SchnegelsbergChief Executive Officer, Director––Aug 28, 2025
Matt SchusterChief Operating Officer––Aug 28, 2025
Bernard SkaggsChief Financial Officer––Aug 28, 2025
George Tiancheng YeDirector––Aug 28, 2025
Richard FangDirector––Aug 28, 2025
Van SamDirector––Aug 28, 2025
Gregory L. Segall10% owner––Nov 13, 2025
Versa Capital Group, LLC10% owner7,943,585339.67%Nov 13, 2025
Sindex SSI Lending, LLC10% owner––Nov 13, 2025
Versa Capital Fund Iii, L.P.10% owner––Nov 13, 2025
Versa UGP-III, LLC10% owner––Nov 13, 2025
Versa FGP-III, L.P.10% owner––Nov 13, 2025

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Sindex SSI Lending, LLC
10% Stockholder
Jun 3, 20263,971,793$1.26MJun 3, 2026debt exchange for equity from the issuer
Sindex SSI Lending, LLC
10% Stockholder
Jun 1, 20263,971,793$695.06KJun 1, 2026debt exchange for equity from the issuer